Clinical Trial

The Harefield Acute Myocardial Infarction Cohort

Study acronym: HEART - ACS
Recruiting
View on ClinicalTrials.gov →
Summary
In this project the investigator's plan to collect blood during a patient's routine angiogram procedure which they will have due to having suffered a heart attack. Data from the patients' routine procedures for this condition, including but not exclusively, ECG, Echocardiogram, MRI scans, will be collected. The aim of the research project is to analyse the blood samples and identify novel biomarkers and clinical parameters associated with acute coronary syndromes. The investigator's will particularly focus on markers of inflammation and micro-organism activity. The investigator's hope that this will help to gain more knowledge about what causes heart disease and how various conditions can be treated more efficiently. The investigator's will follow-up and collect further research data via a questionnaire at the routine 6 weeks and 6 months follow-up appointment after the angiogram procedure. Participants will also be telephoned at one-year post procedure, to update any events and medication status and data will thereafter be collected form data held by the hospital without having to contact the participant. Remaining blood samples will be stored securely for further analysis into blood and other markers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-01-02.
Status change: Not Yet Recruiting → Recruiting 2020-01-13
Trial Details
NCT Number NCT04218344
Lead Sponsor Royal Brompton & Harefield NHS Foundation Trust
Conditions Acute Coronary Syndrome
Enrollment 2,000 participants
Start Date 2020-01-09
Primary Completion 2030-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2020-01-18